Bullboard - Stock Discussion Forum Alpha Cognition Inc ACOG

Healthcare Biotechnology

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062... see more

Add To Watchlist

NDAQ:ACOG - Post Discussion

Alpha Cognition Inc > $ACOG.v CEO Michael McFadden talks Alpha-1062 TBI study

View:

Post by culturedpiggy01 on Dec 21, 2021 4:07pm

$ACOG.v CEO Michael McFadden talks Alpha-1062 TBI study

great video of $ACOG.v CEO Michael McFadden talking about their Alpha-1062 Traumatic Brain Injury Study https://www.youtube.com/watch?v=-QQSJNvmUuc

the inhibitor could be used to treat Alzheimer’s, I highly recommend you check it. Really intriguing stuff

td, $ACOG trading at $1.06 with market cap at $65.19 M

167

Comment

Comment by ferret_ca on Dec 22, 2021 12:25pm

well it doesn't look like the interview or presentation did anything to interest prspective buyers or trigger existing shareholders to add shares, still a bit of tax loss selling, the pushing out next results a bit has definitely hurt. I did add a few over the last couple of days but will keep it to a smaller weighting due to risk and size and my age, lol. cheers, happy holidays and gl& ...more

Comment

Alpha Cognition Inc